During the first half of 2008, Morphosys AG plans to set out the shape of its future drug development strategy, following its mega-scale antibody discovery and development deal with Novartis AG, which the company estimates will deliver $1 billion in cash over the next 10 years. (BioWorld International)

NeuroSearch A/S has completed one of Europe's biggest biotechnology fundraisings in 2007, netting DKK728.7 million (US$145.2 million) in a discounted rights issue. (BioWorld International)